Literature DB >> 16472369

Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.

Po-Lun Wu, Hsien-Yuan Lane, Kuan-Pin Su.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16472369     DOI： 10.1111/j.1440-1819.2006.01469.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN： 1323-1316            Impact factor:   5.188


× No keyword cloud information.
  3 in total

1.  A crossover study on lipid and weight changes associated with olanzapine and risperidone.

Authors:  Kuan-Pin Su; Po-Lun Wu; Carmine M Pariante
Journal:  Psychopharmacology (Berl)       Date:  2005-10-21       Impact factor: 4.530

Review 2.  Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review.

Authors:  Adriana Cimo; Erene Stergiopoulos; Chiachen Cheng; Sarah Bonato; Carolyn S Dewa
Journal:  BMC Psychiatry       Date:  2012-03-23       Impact factor: 3.630

3.  Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.

Authors:  Hsiao-Pei Tsai; Po-Hsun Hou; Frank-Chiahung Mao; Chia-Chia Chang; Wei-Cheng Yang; Ching-Feng Wu; Huei-Jyuan Liao; Tzu-Chun Lin; Lan-Szu Chou; Li-Wei Hsiao; Geng-Ruei Chang
Journal:  Int J Mol Sci       Date:  2021-01-02       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.